The patients were randomized 2:1:1 to receive WEGOVY 2.4 mg, WEGOVY 1.7 mg, or placebo
Little did anyone realize that the research was all pretty much useless
These medications are designed for subcutaneous injection, which means they are delivered into the fatty tissue layer just beneath the skin but above the muscle
Managing this with high-protein, high-fiber foods prevents it from sabotaging results
Reduced Risk of Obesity-related Health Issues: Losing weight with semaglutide can lower the risk of developing various health issues associated with obesity, including sleep apnea, osteoarthritis, and certain types of cancer
Frequently Asked Questions (FAQs) If you have remaining questions related to Ozempic and blood clots, read the additional information below